Effects of St John's wort (Hypericum perforatum L.) extracts on epileptogenesis

Molecules

Volumn 16, Issue 9, 2011, Pages 8062-8075

  Ivetic, Vesna ^a   Trivic, Svetlana ^a   Pogancev, Marija Knezevic ^a   Popovic, Mira ^a   Zlinská, Janka ^b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b University of Central Europe in Skalica   (Slovakia)

Author keywords

Epilepsy; Extracts; Hypericum perforatum L.; Kindling; Rabbits; St. John's wort

Indexed keywords

ANTICONVULSIVE AGENT; PLANT EXTRACT;

ANIMAL; ARTICLE; BRAIN DEPTH STIMULATION; CHEMISTRY; DRUG EFFECT; FEMALE; HYPERICUM; KINDLING; MALE; RABBIT; SEIZURE;

ANIMALS; ANTICONVULSANTS; DEEP BRAIN STIMULATION; FEMALE; HYPERICUM; KINDLING, NEUROLOGIC; MALE; PLANT EXTRACTS; RABBITS; SEIZURES;

EID: 80053283143     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16098062     Document Type: Article

References (36)

1. Wold, R.S.; Lopez, S.T.; Yau, C.L.; Butler, L.M.; Pareo, S.R. Increasing trends in elderly persons' use of nonvitamin, nonmineral dietary supplements and concurrent use of medications. J. Am. Diet. Assoc. 2005, 105, 54-63. (Pubitemid 40075492)
2. Cavaliere, C.; Rea, P.; Lynch, M.E.; Blumenthal, M. Herbal Supplement Sales Experience Slight increase in 2008. HerbalGram 2009, 82, 58-91.
3. Ernst, E. Prevalence of use of complementary/alternative medicine: A systematic review. Bull. World Health Organ. 2000, 78, 252-257. (Pubitemid 30151618)
4. Hodges, P.J.; Kam, P.C.A. The peri-operative implications of herbal medicines. Anaesthesia 2002, 57, 889-899. (Pubitemid 35021512)
5. Stevinson, C.; Ernst, E. A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome. BJOG 2000, 107, 870-876. (Pubitemid 30417343)
6. Bendich, A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J. Am. Coll. Nutr. 2000, 1, 3-12. (Pubitemid 30090438)
7. Ivetic, V.; Filipovic, D. Some neurophysiological parameters in menopausal women and Biosenzal (Hypericum perforatum extract). Neuroscience 1998, 10, 191.04.
8. Bair, Y.A.; Gold, E.B.; Utts, J.M.; Zhang, G.; Rasor, N.; Greendale, G.A.; Upchurch, D.M.; Chyu, L.; Sternfeld, B.; Adler, S. Use of complementary and alternative medicine during the menopause transition: longitudinal results from the Study of Women's Health Across the Nation. Menopause 2008, 15, 32-43.
9. Meoli, A.L.; Rosen, C.; Kristo, D.; Kohrman, M.; Gooneratne, N.; Aguillard, R.N.; Fayle, R.; Troell, R.; Townsend D.; Claman, D.; Hoban, T.; Mahowald, M. Oral Nonprescription Treatment for Insomnia: An Evaluation of Products With Limited Evidence. J. Clin. Sleep Med. 2005, 1, 173-187.
10. Linde, K.; Berner, M.; Egger, M.; Mulrow, C. St John's wort for depression: Meta-analysis of randomized controlled trials. Br. J. Psychiatry 2005, 186, 99-107. (Pubitemid 40193777)
11. Beaubrun, G.; Gray, G.E. A review of herbal medicines for psychiatric disorders. Psychiatr. Serv. 2000, 51, 1130-1134.
12. Barnes, J.; Anderson, L.A.; Phillipson, J.D. St John's wort (Hypericum perforatum L.). A review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 2001, 53, 583-600. (Pubitemid 32457809)
13. Schulz, V. Clinical trials with hypericum extracts in patients with depression-results, comparisons, conclusions for therapy with antidepressant drugs. Phytomedicine 2002, 9, 468-474.
14. Linde, K.; Berner, M.M.; Kriston, L. St John's wort for major depression. Cochrane Database Syst. Rev. 2008, 8, CD000448.
15. Ernst, E.; Rand, J.I.; Stevinson, C. Adverse effects profile of the herbal antidepressant St John's Wort (Hypericum perforatum L). Eur. J. Clin. Pharmacol. 1998, 54, 589-594. (Pubitemid 28531418)
16. Heinrich, M.; Barnes, J.; Gibbons, S.; Williamson, E. Fundamentals of Pharmacognosy and Phytotherapy; Chuchill Livingstone: Edinburgh, UK, 2004.
17. Butterweck, V. Mechanism of Action of St John's Wort in Depression: What is Known? CNS Drugs 2003, 17, 539-562. (Pubitemid 36774135)
18. Zanoli, P. Role of hyperforin in the pharmacological activities of St. John's Wort. CNS Drug Rev. 2004, 10, 203-218. (Pubitemid 39391315)
19. Vollmer, J.J.; Rosenson, J. Chemistry of St. John's Wort: Hypericin and Hyperforin. J. Chem. Educ. 2004, 81, 1450.
20. Smelcerovic, A.; Spiteller, M.; Zuehlke, S. Comparison of Methods for the Exhaustive Extraction of Hypericins, Flavonoids, and Hyperforin from Hypericum perforatum L. J. Agr. Food Chem. 2006, 54, 2750-2753.
21. Avanzini, G.; Franceschett, S. Cellular biology of epileptogenesis. Lancet Neurol. 2003, 2, 133-142.
22. Baraban, S.C., Ed.; Animal Models of Epilepsy Methods and Innovations; Humana Press: New York, NY, USA, 2009; p. 265.
23. Goddard, G.V. Development of epileptic seizures through brain stimulation at low intensity. Nature 1967, 214, 1020-1021.
24. Racine, R.J. Modification of seizure activity by electrical stimulation, I: After-discharge threshold. Electroencephalogr. Clin. Neurophysiol. 1972, 32, 269-279.
25. Ivetic, V.; Popovic, M.; Naumovic, N.; Radenkovic, M.; Vasic, V. The effect of Ginkgo biloba (EGb 761) on epileptic activity in rabbits. Molecules 2008, 13, 2509-2020.
26. Ivetic, V.; Popovic, M.; Mimica-Dukic, N.; Barak, O.; Pilija, V. St. Johnson's wort (Hypericum perforatum L.) and kindling epilepsy in rabbit. Phytomedicine 2002, 9, 496-499.
27. Ivetic, V.; Popovic, M.; Mimica-Dukic, N. Klamath Weed (Hypericum Perforatum L.) and epilepsy at rabbits. Praxis Medica 2001, 28, 1-3.
28. Jakovljevic, V.; Popovic, M.; Mimica-Dukic, N.; Sabo, A.; Gvozdenovic, L. Pharmacodynamic study of Hypericum perforatum L. Phytomedicine 2000, 7, 444-453.
29. Hosseinzadeh, H.; Karimi, G.R.; Rakhshanizadeh, M. Anticonvulsant effect of Hypericum perforatum: role of nitric oxide. J. Ethnopharacol. 2005, 98, 207-298.
30. Heim, K.E.; Tagliaferro, A.R.; Bobilzya, D.J. Flavonoid antioxidans chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 2002, 2, 853-867.
31. Erdelmeier, C.A.J.; Koch, E.; Hoerr, R. Hypericum perforatum-St. John's Wort chemical, pharmacological and clinical aspects. Stud. Nat. Prod. Chem. 2000, 22, 643-716.
32. Müller, W.E. Current St John's wort research from mode of action to clinical efficacy. Pharmacol. Res. 2003, 4, 101-109. (Pubitemid 36263444)
33. Calapai, G.; Crupi, A.; Firenzuoli, F.; Inferrera, G.; Squadrito, F.; Parisi, A.; DeSarro, G.; Caputi, A. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Pharmacopsychiatry 2001, 34, 45-49. (Pubitemid 32221748)
34. Muller, W.E.; Singer, A.; Wonnemann, M.; Hafner, U.; Rolli, M.; Schäfer, C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 1998, 31, 16-21. (Pubitemid 28294221)
35. Butterweck, V.; Böckers, T.; Korte, B.; Wittkowski, W.; Winterhoff, H. Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus. Brain Res. 2002, 930, 21-29. (Pubitemid 34195624)
36. Shek, J.W.; Wen, G.Y.; Wisniewski, H.M. Atlas of the Rabbit Brain and Spinal Cord; Karger AG: Basel, Switzerland, 1986; p. 140